13 Oct 2023
// ONCLIVE
https://www.onclive.com/view/lirafugratinib-elicits-durable-responses-across-several-fgfr2-solid-tumors
12 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/12/2759649/0/en/Relay-Therapeutics-Announces-Initial-RLY-4008-lirafugratinib-Data-Demonstrating-Durable-Responses-Across-Multiple-FGFR2-Altered-Solid-Tumors.html
LOOKING FOR A SUPPLIER?